VEGF-2 DNA vaccine (LACDR)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVEGF-2 DNA vaccine (LACDR)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionVascular endothelial growth factor receptor 2 modulators

TargetsVascular endothelial growth factor receptor 2

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLeiden/Amsterdam Center for Drug Research

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLeiden/Amsterdam Center for Drug Research

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A